Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Large down gaps, monthly chart 2019 July & August
View:
Post by floatinketucky on Dec 21, 2021 8:51am

Large down gaps, monthly chart 2019 July & August

2019 July        Monthly     High   .3920    Low .2370
2019 August    Monthly     High  .2609  Low .1636
2019 August  Monthly gap filled - 2021 November
2021 November  Monthly  Low  .1636   High . 2609 

July 2019 Monthly Down gap fill in progress - Dec 2021. 
2021 December  Monthly   Low  .1950  High . 2989 
Current .248
Comment by robertshaw on Dec 21, 2021 9:29am
Yes, the huge gap down time, that's time Blowjobjoe's bosses got the stink PP informations at least 2 months ahead of all the long shareholders, naked shorted all the way from around 0.6 (With the great news of Patient 6 cancer free for over 360 days till the 5th patient 18 months cancer free), at Aug 22nd, naked shorting peaked over 20 Million shares in a single day... And shorted the ...more  
Comment by floatinketucky on Dec 21, 2021 9:48am
TORONTO, ON / ACCESSWIRE / January 31, 2019 / Theralase Technologies Inc. ("Theralase®" or the "Company") (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds ("PDCs") and their associated drug formulations intended to safely and effectively destroy various ...more  
Comment by floatinketucky on Dec 21, 2021 9:54am
At the closing of the phase one study buyers were looking for the next buisness devlopment and it was a long ways out. The price fall began in March. Other investers soon realized how far out the next signifigant steps would be taken for Phase 2 Pivitol. And the market forces propelled.  The market forces are again propelling in the opposite. 
Comment by floatinketucky on Dec 28, 2021 4:29pm
Then phase 2 patients were undertreated sigfifigantly.. July 30, 2 Study Treatment Optimizations: Additional optimizations to the clinical study protocol that have been implemented for all future patients to be enrolled and treated in Study II and for the five patients yet to receive their second treatment, include: Bladder Volume Calculation:  The clinical protocol did not clearly ...more  
Comment by floatinketucky on Dec 21, 2021 9:31am
2021 November  Monthly  Low  .1366  High .2206
Comment by floatinketucky on Dec 24, 2021 9:30am
it appears the gap is closing.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250